190
Views
2
CrossRef citations to date
0
Altmetric
Antimicrobial Original Research Papers

Emergency department care of ABSSSI with dalbavancin infusion, direct discharge, and outpatient telemedicine follow up: a study protocol

ORCID Icon, , , , , , , & show all
Pages 397-403 | Received 30 Dec 2021, Accepted 06 Oct 2022, Published online: 20 Oct 2022

References

  • Stevens DL. Treatments for skin and soft-tissue and surgical site infections due to MDR gram-positive bacteria. J Infect. 2009;59(SUPPL. 1):S32–S39.
  • Moran GJ, Krishnadasan A, Gorwitz RJ, et al. Methicillin-resistant S. aureus infections among patients in the emergency department. N Engl J Med. 2006;355(7):666–674.
  • Pallin DJ, Egan DJ, Pelletier AJ, et al. Increased US emergency department visits for skin and soft tissue infections, and changes in antibiotic choices, During the emergence of Community-Associated Methicillin-Resistant Staphylococcus aureus. Ann Emerg Med. 2008;51(3):291–298.
  • US Food and Drug Administration. Acute bacterial skin and skin structure infections: developing drugs for treatment. Acute bacterial skin and skin structure infections: developing drugs for treatment. Guidance for industry. 2013.
  • Weng QY, Raff AB, Cohen JM, et al. Costs and consequences associated with misdiagnosed lower extremity cellulitis. JAMA Dermatol. 2017;153(2):141–146.
  • Chang AM, Cohen DJ, Lin A, et al. Hospital strategies for reducing emergency department crowding: a mixed-methods study. Ann Emerg Med. 2018;71(4):497–505.e4.
  • Derlet RW, Richards JR, Kravitz RL. Frequent overcrowding in U.S. Emergency departments. Acad Emergency Med. 2001;8(2):151–155.
  • Bosso JA, Casapao AM, Edwards J, et al. Clinical pathway for moderate to severe acute bacterial skin and skin structure infections from a US perspective: a roundtable discussion. Hosp Pract (1995). 2016;44(4):183–189.
  • Talan DA, Salhi BA, Moran GJ, et al. Factors associated with decision to hospitalize emergency department patients with skin and soft tissue infection. West J Emerg Med. 2015;16(1):89–97.
  • Koziatek C, Klein N, Mohan S, et al. Use of a telehealth follow-up system to facilitate treatment and discharge of emergency department patients with severe cellulitis. Am J Emerg Med. 2021;41:184–189.
  • Patel M, Smalley S, Dubrovskaya Y, et al. Dalbavancin use in the emergency department setting. Ann Pharmacother. 2019;53(11):1093–1101.
  • Jensen IS, Wu E, Fan W, et al. Use of oritavancin in moderate-to-severe ABSSSI patients requiring iv antibiotics: a U.S. payer budget impact analysis. J Manag Care Spec Pharm. 2016;22(6):752–764.
  • Gough F, Budhrani S, Cohn E, et al. ATA practice guidelines for live, on-demand primary and urgent care. Telemed J E Health. 2015;21(3):233–241.
  • Talan DA, Mower WR, Lovecchio FA, et al. Pathway with single‐dose long‐acting intravenous antibiotic reduces emergency department hospitalizations of patients with skin infections. Acad Emerg Med. 2021;28(10):1108–1117.
  • Krsak M, Morrisette T, Miller M, et al. Advantages of outpatient treatment with long-acting lipoglycopeptides for serious gram-positive infections: a review. Pharmacotherapy. 2020;40(5):469–478.
  • Andreoni M, Bassetti M, Corrao S, et al. The role of dalbavancin for gram positive infections in the COVID-19 era: state of the art and future perspectives. Expert Rev Anti Infect Ther. 2021;19(9):1125–1134.
  • Mower WR, Kadera SP, Rodriguez AD, et al. Identification of clinical characteristics associated with high-level care among patients with skin and soft tissue infections. Ann Emerg Med. 2019;73(4):366–374.
  • Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA. 2016;315(8):801–810.
  • Mower WR, Crisp JG, Krishnadasan A, et al. Effect of initial bedside ultrasonography on emergency department skin and soft tissue infection management. Ann Emerg Med. 2019;74(3):372–380.
  • Glauser W. Proposed protocol to keep COVID-19 out of hospitals. CMAJ. 2020;192(10):E264–E265.
  • Caminiti C, Meschi T, Braglia L, et al. Reducing unnecessary hospital days to improve quality of care through physician accountability: a cluster randomised trial. BMC Health Serv Res. 2013;13(1):14.
  • Durante-Mangoni E, Gambardella M, Iula VD, et al. Current trends in the real-life use of dalbavancin: report of a study panel. Int J Antimicrob Agents. 2020;56(4):106107.
  • Dunne MW, Talbot GH, Boucher HW, et al. Safety of dalbavancin in the treatment of skin and skin structure infections: a pooled analysis of randomized, comparative studies. Drug Saf. 2016;39(2):147–157.
  • O'Connor DM, Jew OS, Perman MJ, et al. Diagnostic accuracy of pediatric teledermatology using parent-submitted photographs a randomized clinical trial. JAMA Dermatol. 2017;153(12):1243–1248.
  • Simonetti O, Rizzetto G, Molinelli E, et al. Review: a safety profile of dalbavancin for onand off-label utilization. Ther Clin Risk Manag. 2021;17:223–232.
  • Hersh AL, Chambers HF, Maselli JH, et al. National trends in ambulatory visits and antibiotic prescribing for skin and soft-tissue infections. Arch Intern Med. 2008;168(14):1585–1591.
  • Ektare V, Khachatryan A, Xue M, et al. Assessing the economic value of avoiding hospital admissions by shifting the management of gram + acute bacterial skin and skin-structure infections to an outpatient care setting. J Med Econ. 2015;18(12):1092–1101.
  • Barbic D, Chenkin J, Cho DD, et al. In patients presenting to the emergency department with skin and soft tissue infections what is the diagnostic accuracy of point-of-care ultrasonography for the diagnosis of abscess compared to the current standard of care? A systematic review and Meta-an. BMJ Open. 2017;7(1):e013688.
  • Tayal VS, Hasan N, Norton HJ, et al. The effect of soft-tissue ultrasound on the management of cellulitis in the emergency department. Acad Emerg Med. 2006;13(4):384–388.
  • Brandon CT, Kang T. Not what it seems: deep tissue infection presenting as cellulitis. West J Emerg Med. 2015;16(5):766–767.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.